Lisa Butterfield PhD

Lisa Butterfield is a Distinguished Scientist at Merck and an Adjunct Professor of Microbiology and Immunology at the University Of California, San Francisco. Her research has been focused on cancer vaccines, immune profiling, and cellular therapies for melanoma, hepatocellular cancer, and other tumor types. She was most recently Vice President, Research and Development at the Parker Institute for Cancer Immunotherapy, where she supported cell therapy initiatives and clinical trial biospecimen and biomarker projects. Lisa was also the first female President of the Society of Immunotherapy of Cancer (SITC) and a member of the SITC Executive Committee. Previously a tenured Professor of Medicine, Surgery, Immunology, and Clinical and Translational Science at the University of Pittsburgh and Director of the Hillman Cancer Center Immunologic Monitoring and Cellular Products Laboratory, she earned a PhD in Biology from UCLA, followed by postdoctoral fellowships in Cellular Immunology and Cancer Gene Therapy also at UCLA.